Cryotherapy Helps Reduce Chemotherapy Neuropathy Risk
A promising low-risk approach to mitigate nerve damage in cancer patients undergoing chemotherapy
Topline
Emerging evidence suggests that cryotherapy significantly lowers the risk of chemotherapy-induced peripheral neuropathy (CIPN), particularly in patients receiving taxane-based chemotherapy. Despite encouraging results, adoption remains limited due to awareness gaps and the absence of standardized protocols.
Study Details
Chemotherapy-induced periph…
Keep reading with a 7-day free trial
Subscribe to Just Healthcare to keep reading this post and get 7 days of free access to the full post archives.